March 25th 2024
The role of the US President’s Emergency Plan for AIDS Relief in combating tuberculosis (TB).
Triumeq PD Positive Opinion Brings Europe Closer to Closing HIV Treatment Gap in Children
December 16th 2022Europe’s Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion for Triumeq PD, the first dispersible single tablet regimen with dolutegravir, for children living with HIV.
Read More
If Priced Right, Long-Acting Injectable Cabotegravir Could Reduce Spread of HIV
December 13th 2022For this to be a viable HIV reduction strategy, scale-up demand creation should be coordinated between all partners, the study authors said, and should be fast enough to build momentum and yield the expected results.
Read More
Treatment Options for Heavily Treatment-Experienced Patients with Multi-Drug Resistant HIV
November 25th 2022Joseph Eron, MD, Daniel R. Kuritzkes, MD, and Monica Gandhi, MD, MPH, explore the relative pros and cons of various agents and drug classes that may be used for the treatment of multi-drug resistant HIV.
Watch
HIV and Aging in the Era of Antiretroviral Therapy: Considerations in Clinical Care
October 28th 2022With the population of adults with HIV growing older, incorporating age-based screenings, comprehensive assessments, and morbidity management into routine HIV care is essential in improving health outcomes and quality of life.
Read More
PREMISE: Bacterial STI Prophylaxis Failed to Cut Infection Rates for Pregnant Women Living With HIV
October 19th 2022The phase IIb trial evaluated whether adding a novel regimen of monthly azithromycin to a daily dose of trimethoprim-sulfamethoxazole would decrease the rate of STI at time of delivery among pregnant women living with HIV in Cameroon.
Read More